Diabetes mellitus in patients with cirrhosis: clinical implications and management (Q38773241)

6 September 2017

Diabetes mellitus in patients with cirrhosis: clinical implications and management (English)

1 reference

6 September 2017

Pierre-Emmanuel Rautou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Dominique C Valla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Valérie Paradis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Richard Moreau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Laure Elkrief

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shiv Sarin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

12 March 2016

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

936-948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 June 2020

cites work

1 reference

Mortality from chronic liver diseases in diabetes

21 January 2018

1 reference

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study

21 January 2018

1 reference

Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study

21 January 2018

1 reference

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

21 January 2018

1 reference

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

Hepatic inflammation and fibrosis: functional links and key pathways

21 January 2018

1 reference

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

Progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Hepatocyte death: a clear and present danger

21 January 2018

1 reference

Diabetes and apoptosis: liver

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

21 January 2018

1 reference

Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox.

21 January 2018

1 reference

High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells

21 January 2018

1 reference

Angiogenesis in liver disease

21 January 2018

1 reference

Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.

21 January 2018

1 reference

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

21 January 2018

1 reference

Liver sinusoidal endothelial cells in hepatic fibrosis

21 January 2018

1 reference

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

21 January 2018

1 reference

Diabetes in chronic liver disease: from old concepts to new evidence

21 January 2018

1 reference

Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?

21 January 2018

1 reference

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

21 January 2018

1 reference

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

21 January 2018

1 reference

Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.

21 January 2018

1 reference

Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis

21 January 2018

1 reference

Abnormal tissue oxygenation in patients with cirrhosis and liver failure

21 January 2018

1 reference

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

21 January 2018

1 reference

Hypoxia and hypoxia inducible factors: diverse roles in liver diseases

21 January 2018

1 reference

Hypoxia-inducible factors in physiology and medicine

21 January 2018

1 reference

Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets

21 January 2018

1 reference

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

21 January 2018

1 reference

RETRACTED: Betatrophin: a hormone that controls pancreatic β cell proliferation

21 January 2018

1 reference

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

21 January 2018

1 reference

Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity

21 January 2018

1 reference

Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.

21 January 2018

1 reference

Plasma betatrophin levels in patients with liver cirrhosis

21 January 2018

1 reference

Clinical implications of hepatogenous diabetes in liver cirrhosis

21 January 2018

1 reference

Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis

21 January 2018

1 reference

Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

21 January 2018

1 reference

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

21 January 2018

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.

21 January 2018

1 reference

Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.

21 January 2018

1 reference

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

Long-term outcomes of liver transplantation: diabetes mellitus

21 January 2018

1 reference

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

Associations of chronic hepatitis C with metabolic and cardiac outcomes

21 January 2018

1 reference

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease

21 January 2018

1 reference

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

21 January 2018

1 reference

Renal failure in cirrhosis

21 January 2018

1 reference

Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.

21 January 2018

1 reference

Metformin inhibits glutaminase activity and protects against hepatic encephalopathy

21 January 2018

1 reference

A randomized controlled trial of acarbose in hepatic encephalopathy

21 January 2018

1 reference

Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure

21 January 2018

1 reference

Disorders of gastrointestinal motility associated with diabetes mellitus

21 January 2018

1 reference

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

21 January 2018

1 reference

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

21 January 2018

1 reference

Infections and diabetes: mechanisms and prospects for prevention

21 January 2018

1 reference

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

21 January 2018

1 reference

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

21 January 2018

1 reference

Severe sepsis in cirrhosis.

21 January 2018

1 reference

Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value

21 January 2018

1 reference

Antecedent liver disease and drug toxicity

21 January 2018

1 reference

Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease

21 January 2018

1 reference

Metformin-associated lactic acidosis in a patient with liver disease

21 January 2018

1 reference

Metformin-associated lactic acidosis: a prognostic and therapeutic study.

21 January 2018

1 reference

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

21 January 2018

1 reference

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes

21 January 2018

1 reference

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

Pharmacological agents for NASH.

21 January 2018

1 reference

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis.

21 January 2018

1 reference

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

21 January 2018

1 reference

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

21 January 2018

1 reference

Diabetes as a risk factor for infections in cirrhosis

21 January 2018

1 reference

Expanding consensus in portal hypertension

21 January 2018

1 reference

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

21 January 2018

1 reference

Determination of glycated hemoglobin in patients with advanced liver disease

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.3748/WJG.V10.I15.2284

Identifiers

DOI

10.1111/LIV.13115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26972930%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference